Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 21;14:3833–3848. doi: 10.2147/OTT.S309917

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Yu et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

The heatmaps and Venn Diagrams showed the differential circRNAs in prostate cancer (PCa). (A) Heatmaps of the differentially expressed circRNAs comparing Gleason>8 with Gleason<6 in GSE113153. (B) Heatmaps of the differentially expressed circRNAs comparing enzalutamide-sensitive LNcap cell with high enzalutamide resistant LNcap cell in GSE118959. (C) Heatmaps of the differentially expressed circRNAs comparing enzalutamide-sensitive LNcap cell with moderately enzalutamide resistant LNcap cell in GSE118959. Venn Diagrams showing the overlap of significantly upregulated (D) and downregulated (E) circRNAs between GSE113153 and GSE118959.

Abbreviations: LNcap-Enz-HR, high enzalutamide resistant LNcap cell; LNcap-Enz-LR, moderately enzalutamide resistant LNcap cell; LNcap-Enz-S, enzalutamide-sensitive LNcap cell.